Drug Shortage Report for LMD 10% IN DEXTROSE 5%

Last updated on 2024-05-15 History
Report ID 213206
Drug Identification Number 00224235
Brand name LMD 10% IN DEXTROSE 5%
Common or Proper name LMD 10% IN DEXTROSE 5%
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DEXTROSE DEXTRAN
Strength(s) 5% 10%
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 12 X 500ML
ATC code B05AA
ATC description BLOOD AND RELATED PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-01-31
Estimated end date 2024-08-30
Actual end date
Shortage status Actual shortage
Updated date 2024-05-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-12-13 English Compare
v2 2023-12-13 French Compare
v3 2024-01-31 English Compare
v4 2024-01-31 French Compare
v5 2024-02-01 English Compare
v6 2024-02-28 English Compare
v7 2024-02-28 French Compare
v8 2024-04-10 English Compare
v9 2024-04-10 French Compare
v10 2024-05-15 English Compare
v11 2024-05-15 French Compare

Showing 1 to 11 of 11